MedPlus Health Services reported a significant rise in financial performance for the quarter and financial year ended March 31, 2026. The company's revenue for Q4 FY26 stood at ₹18,644m, marking a 23.5% increase compared to the same period in the previous year. Sequentially, revenue grew by 3.2% from the preceding quarter. The full fiscal year 2026 revenue reached ₹68,925m, a 12.3% increase over FY25.

Financial Performance

The company's profitability metrics improved during the quarter. Net profit for Q4 FY26 was ₹640m, up 24.6% year-on-year. For the full year, net profit surged 46.2% to ₹2,196.1m. EBITDA for the quarter rose to ₹1.69B compared to ₹1.4B in Q4 FY25, with the EBITDA margin improving marginally to 9.07% from 9.03% year-on-year. Operating EBITDA for the quarter stood at ₹1,076m, representing a margin of 5.8%, compared to 5.3% in Q4 FY25. On a full-year basis, operating EBITDA stood at ₹3,658m with a margin of 5.3%.

The following table summarises the key financial metrics for the quarter:

Operational Highlights

MedPlus expanded its store network significantly during the fiscal year. The company added 618 stores on a net basis, bringing the total count to 5,330 stores as of March 31, 2026. In Q4 FY26 alone, the company added 218 stores net, with 295 gross additions and 77 closures. The expansion strategy focused on deeper penetration in existing clusters and growth beyond Tier-One cities, with 384 net additions recorded beyond Tier-One areas during the year.

Segment and Store Metrics

The pharmacy segment remained the primary revenue driver, contributing ₹18,266m in revenue for Q4 FY26. Stores older than 12 months demonstrated strong operational efficiency, reporting a store-level EBITDA margin of 13.1% and an operating ROCE of 80.0% for the quarter. The company's gross margin for the quarter improved to 26.5%, while the full-year gross margin stood at 26.2%, an increase of 180 basis points over FY25.

medplus health services has announced the resignation of its Company Secretary and Compliance Officer, Mr. Manoj Kumar Srivastava. The resignation was submitted via a letter dated May 5, 2026, and was accepted by the company's Board of Directors during its meeting held on May 20, 2026.

The Board placed on record its sincere appreciation for the contributions made by Mr. Srivastava during his tenure. He is stepping down from the position of Key Managerial Personnel (KMP) to pursue another career opportunity outside the organization. The resignation is effective from the close of business hours on May 20, 2026.

Details of the Change

The disclosure regarding the change in key managerial personnel was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The specific details regarding the cessation are outlined below:

In his resignation letter, Mr. Srivastava expressed his gratitude to the Chairman, Managing Director & CEO, the Board Members, and senior management for their trust and support. He confirmed his commitment to ensuring a smooth transition and extending full support during the handover process of his responsibilities.